Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Sep;10(Suppl 26):S3060-S3063.
doi: 10.21037/jtd.2018.08.134.

Renal denervation with ultrasound therapy (paradise device) is an effective therapy for systemic hypertension

Affiliations
Editorial

Renal denervation with ultrasound therapy (paradise device) is an effective therapy for systemic hypertension

Sho Torii et al. J Thorac Dis. 2018 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Sho Torii receives research grants from SUNRISE lab. Renu Virmani and Aloke V. Finn have received institutional research support from Abbott Vascular, Boston Scientific, Cook Medical, Cardiovascular Systems, Inc., Medtronic, ReCor Medical, and Terumo Corporation; Renu Virmani is a consultant for 480 Biomedical, Abbott Vascular, Medtronic, and W.L. Gore. The other authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Diagram of renal artery and circumferential peri-arterial nerve location. Note the distal regions of renal artery had sympathetic peri-renal nerves located closer to the renal artery as compared to proximal and middle segments, however, the nerves were far smaller and fewer in the distal regions compared to proximal and middle regions.
Figure 2
Figure 2
Representative images of ablation using paradise ultrasound renal denervation catheter in swine renal artery. The ablation area is delineated by a green line. Note 360-degree circumferential ablation. A, artery; V, vein.

Comment on

References

    1. Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016;387:957-67. 10.1016/S0140-6736(15)01225-8 - DOI - PubMed
    1. Kumbhani DJ, Steg PG, Cannon CP, et al. Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis. Eur Heart J 2013;34:1204-14. 10.1093/eurheartj/ehs368 - DOI - PubMed
    1. Esler MD, Krum H, Sobotka PA, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010;376:1903-9. 10.1016/S0140-6736(10)62039-9 - DOI - PubMed
    1. Krum H, Schlaich MP, Sobotka PA, et al. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet 2014;383:622-9. 10.1016/S0140-6736(13)62192-3 - DOI - PubMed
    1. Bhatt DL, Kandzari DE, O’Neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014;370:1393-401. 10.1056/NEJMoa1402670 - DOI - PubMed